McIntyre, Freedman & Flynn Investment Advisers’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.85M Sell
22,154
-7,850
-26% -$919K 1.71% 19
2026
Q1
$3.61M Buy
30,004
+147
+0.5% +$17K 2.05% 16
2025
Q4
$3.14M Sell
29,857
-2,083
-7% -$196K 1.97% 16
2025
Q3
$2.68M Sell
31,940
-249
-0.8% -$20.5K 1.61% 23
2025
Q2
$2.55M Buy
32,189
+201
+0.6% +$16K 1.8% 18
2025
Q1
$2.87M Buy
31,988
+1
+0% +$93 2.11% 17
2024
Q4
$3.18M Buy
31,987
+101
+0.3% +$10.4K 2.38% 12
2024
Q3
$3.62M Sell
31,886
-75
-0.2% -$8.91K 2.58% 10
2024
Q2
$3.96M Sell
31,961
-29
-0.1% -$3.74K 2.85% 6
2024
Q1
$4.22M Sell
31,990
-574
-2% -$70.8K 3.07% 6
2023
Q4
$3.55M Buy
32,564
+1
+0% +$104 2.84% 6
2023
Q3
$3.35M Sell
32,563
-99
-0.3% -$10.7K 2.83% 6
2023
Q2
$3.77M Sell
32,662
-2,000
-6% -$227K 3.22% 5
2023
Q1
$3.69M Buy
34,662
+1
+0% +$108 3.13% 6
2022
Q4
$3.85M Buy
+34,661
New +$3.54M 3.18% 7

Other funds holding MRK

McIntyre, Freedman & Flynn Investment Advisers's MRK Position: Q2 2026 in Review

McIntyre, Freedman & Flynn Investment Advisers reduced its Merck (MRK) stake by 26% in Q2 2026, selling an estimated $919K and leaving 22,154 shares worth $2.85M. The position accounts for 1.71% of the portfolio, ranked #19.

McIntyre, Freedman & Flynn Investment Advisers first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.22M in Q1 2024. 3,104 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • McIntyre, Freedman & Flynn Investment Advisers held 22,154 shares of Merck worth $2.85M as of Q2 2026.
  • McIntyre, Freedman & Flynn Investment Advisers sold 7,850 Merck shares in Q2 2026, an estimated $919K.
  • Merck made up 1.71% of McIntyre, Freedman & Flynn Investment Advisers's portfolio in Q2 2026, its #19 holding.
  • McIntyre, Freedman & Flynn Investment Advisers first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • McIntyre, Freedman & Flynn Investment Advisers's Merck position peaked at $4.22M in Q1 2024.
  • 3,104 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on McIntyre, Freedman & Flynn Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.